Alzheimer's Drug Trial Put on Hold

THA, a drug that was widely touted as a treatment for Alzheimer's disease, has been temporarily shelved. Signs of liver damage in test patients has forced further research on the drug.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Science (American Association for the Advancement of Science) 1987-11, Vol.238 (4830), p.1041-1042
1. Verfasser:	Marx, Jean L.
Format:	Artikel
Sprache:	eng
Schlagworte:	Alzheimer Disease - diagnosis Alzheimer Disease - drug therapy Alzheimer's disease Alzheimers disease Aminoacridines - adverse effects Anti-Alzheimer's disease agents Brain damage Clinical trials Clinical Trials as Topic Dosage Drug therapy Drugs Enzymes Experimentation Humans Liver Medical research Nervous system diseases Parkinson disease Research News Sommers, William Symptoms Tacrine Tacrine - adverse effects Testing
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	THA, a drug that was widely touted as a treatment for Alzheimer's disease, has been temporarily shelved. Signs of liver damage in test patients has forced further research on the drug.
ISSN:	0036-8075 1095-9203
DOI:	10.1126/science.3317822